- APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapyLau, George*; Yu, Ming-Lung*; Wong, Grace; Thompson, Alexander; Ghazinian, Hasmik; Hou, Jin-Lin; Piratvisuth, Teerha; Jia, Ji-Dong; Mizokami, Masashi; Cheng, Gregory; Chen, Guo-Feng; Liu, Zhen-Wen; Baatarkhuu, Oidov; Cheng, Ann Lii; Ng, Woon Leung; Lau, Patrick; Mok, Tony; Chang, Jer-Ming; Hamid, Saeed; Dokmeci, A. Kadir; Gani, Rino A.; Payawal, Diana A.; Chow, Pierce; Park, Joong-Won; Strasser, Simone, I; Mohamed, Rosmawaiti; Win, Khin Maung; Tawesak, TanwandeeHepatology International, 2021, 15(5): 1031-1048.被引 47
- Editorial: only steps away from primetime? Hepatitis B virus RNA as a routine marker to guide HBV treatment decisions-authors' replyXia, Muye; Chi, Heng; Janssen, Harry L. A.; Peng, Jie*Alimentary Pharmacology and Therapeutics, 2021, 54(7): 972-973.
- Letter to the Editor: Cautious interpretation of the association between finite treatment and better prognosis in initially HBeAg-negative hepatitis B patients with cirrhosisDeng, Rui; Wang, Ziyan; Liu, Yuxin; Sun, Jian*Hepatology, 2023.
期刊论文
APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy (vol 15, pg 1031, 2021)
4阅读
